Sourasky Medical Center (Ichilov)
Sourasky Medical Center (Ichilov)
Israel, Tel Aviv
Ari Raphael
29 years of experience
accreditations :
Clinic is certified :
CyberKnife in Tel Aviv typically costs from $19,500 to $32,000. Prices depend on the number of sessions, tumor complexity, and the clinic category. In the US, similar procedures cost around $55,000 on average. Tel Aviv offers savings of around 62%. This includes the initial mapping, robotic radiosurgery sessions, and follow-up imagings.
Bookimed Expert Insight: Tel Aviv is Israel's primary hub for advanced oncology, concentrating technology like the Elekta Unity MR-Linac. Leading clinics, such as Sourasky Medical Center (Ichilov), offer JCI-accredited care under directors like Dr. Orit Gutfeld. Choosing a public hospital like Ichilov provides access to heavy patient volumes and scientific expertise. Private facilities like Assuta allow for faster scheduling and physician choice. Both options provide significant savings compared to US treatment standards.
| Israel | Turkey | Austria | |
| CyberKnife | from $17,500 | from $4,750 | from $50,000 |
| CyberKnife for prostate cancer | from $17,500 | from $25,000 | from $25,000 |
| CyberKnife for brain tumor | from $17,800 | from $4,750 | from $35,000 |
| CyberKnife for lung cancer | - | from $6,000 | - |
Day 1
Day 2
Day 3
Day 4
Day 5
Week 1-2
Week 3-4
Week 5-6
Note: The above timeline is a general guide. Each patient"s case is unique and the timeline may vary. Regular transfers are provided, but accommodation is not included in the service.
Dr. Ari Raphael leads the Israeli National Genomic Medicine Initiative at TASMC and specializes in precision oncology for lung and breast cancer.
Director of Radiotherapy Institute Oncology Division at Sourasky Medical Center – Dr. Gutfeld leads a specialized team for precision radiation therapy.
The doctor is a highly experienced oncologist and radiologist, specializing in the diagnosis and treatment of cancer. With a focus on advanced imaging techniques and personalized cancer therapies, the doctor has contributed significantly to the field through both clinical practice and research. The doctor has been involved in numerous clinical trials aimed at improving patient outcomes and has published extensively in peer-reviewed medical journals. The doctor is board-certified in both oncology and radiology, demonstrating a commitment to maintaining the highest standards of medical care.